Pubblicazioni ufficiali Daiichi Sankyo Co., Ltd.

Azioni

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 28/06/2024			Variaz. 5gg	Var. 1 gen.
5.524 ^JPY	+0,33%		+1,36%	+42,67%

27/06	La FDA statunitense rifiuta di approvare il farmaco antitumorale 'missile guidato' di Merck-Daiichi	RE
27/06	La presentazione della BLA di Patritumab Deruxtecan riceve una Lettera di Risposta Completa dall'FDA a causa di accertamenti ispettivi presso un produttore terzo.	CI

Half-year report	04/11/22	CO
1st-half-year results	31/10/22	CO
Slide show half-year results	31/10/22	CO
Integrated report	28/10/22	CO
Integrated report	28/10/22	CO
1st quarter report	03/08/22	CO
Slide show Q1	29/07/22	CO
1st quarter results	29/07/22	CO
Financial report	27/06/22	CO
Minutes of the general assembly	27/06/22	CO
Shareholders meeting voting results	27/06/22	CO
Mixed general shareholder meeting	30/05/22	CO
Slide show results	27/04/22	CO
Annual results	27/04/22	CO
3rd quarter report	07/02/22	CO
Slide show Q3	31/01/22	CO
3rd quarter results	31/01/22	CO
Half-year report	08/11/21	CO
Slide show half-year results	29/10/21	CO
1st-half-year results	29/10/21	CO
1st quarter report	05/08/21	CO
Slide show Q1	30/07/21	CO
1st quarter results	30/07/21	CO